An analgesic evaluation of isoxsuprine in horses

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 51, Issue 7-8, 2004, Pages 370-374

  Lizarraga, I ^a,b   Castillo, F ^a,b   Valderrama, M E ^a,b  

^a MASSEY UNIVERSITY   (New Zealand)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE; EQUUS CABALLUS;

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOXSUPRINE; VASODILATOR AGENT;

ANALGESIA; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD FLOW; DRUG EFFECT; HORSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHYSIOLOGY; RANDOMIZATION; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ANALGESIA; ANIMALS; HORSES; INJECTIONS, INTRAVENOUS; ISOXSUPRINE; MALE; RANDOM ALLOCATION; REGIONAL BLOOD FLOW; VASODILATION; VASODILATOR AGENTS;

EID: 16644395936     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2004.00659.x     Document Type: Article

References (37)

1. Adair, H. S., J. L. Schmidhammer, D. O. Goble, E. M. Green, and C. Rivera-Walker, 1997: Effects of acepromazine maleate, isoxsuprine hydrochloride and prazosin hydrochloride on laminar microcirculatory blood flow in healthy horses. J. Equine Vet. Sci. 17, 599-603.
2. Akerlund, M., and K. E. Andersson, 1977: Relief of pain in primary dysmenorrhoea by beta-adrenoceptor stimulating drugs. Acta Obstet. Gynecol. Scand. 56, 255-256.
3. Al-Jam'a, A. H., I. A. Al-Dabbous, M. S. Raquif, A. Al-Khatti, A. H. Al-Salem, A. A. Baharna, and M. Boholaiga, 1999: Isoxsuprine in the treatment of sickle cell painful crises: a double-blind comparative study with narcotic analgesic. Ann. Saudi Med. 19, 97-100.
4. Baxter, G. M., R. L. Tackett, and J. N. Moore, 1989: Reactivity of equine palmar digital arteries and veins to vasodilating agents. Vet. Surg. 18, 221-226.
5. Belloli, C., R. Carcano, F. Arioli, and C. Beretta, 2000: Affinity of isoxsuprine for adrenoceptors in equine digital artery and implications for vasodilatory action. Equine Vet. J. 32, 119-124.
6. Bentley, G., and J. Starr, 1986: The antinoceptive action of some β-adrenoceptor agonist in mice. Br. J. Pharmacol. 88, 515-521.
7. Bosken, J. M., A. F. Lehner, A. Hunsucker, J. D. Harkins, W. E. Woods, W. Karpiesiuk, W. G. Carter, J. Boyles, M. Fisher, and T. Tobin, 2000: Direct MS-MS identification of isoxsuprine-glucuronide in post-administration equine urine. Can. J. Vet. Res. 64, 112-116.
8. Brumbaugh, G. W., L. H. Sumano, and M. L. Hoyos, 1999: The pharmacologic basis for treatment of developmental and acute laminitis. Vet. Clin. North Am. Equine Pract. 15, 354-362.
9. Brunson, D. B., and L. J. Majors, 1987: Comparative analgesia of xylazine, xylazine/morphine, xylazine/butorphanol, and xylazine/nalbuphine in the horse, using dental dolorimetry. Am. J. Vet. Res. 48, 1087-1091.
10. Calixto, J. B., and C. M. Simas, 1984: Mechanism of action of isoprenaline, isoxsuprine, terbutaline and orciprenaline on gravid human isolated myometrium. Influence of the neuronal uptake process. Biol. Reprod. 30, 1117-1123.
11. Chambers, J. P., A. Livingston, and A. E. Waterman, 1990: A device for testing nociceptive thresholds in horses. J. Assoc. Vet. Anaesth. 17, 42-44.
12. Chambers, J. P., A. Livingston, A. E. Waterman, and A. E. Goodship, 1993: The analgesic effects of detomidine in thoroughbred horses with chronic tendon injury. Res. Vet. Sci. 54, 52-56.
13. Cook, P., and I. James, 1981: Medical intelligence: drug therapy. N. Engl J. Med. 305, 1560-1564.
14. Deumer, J., F. de Haan, M. Th. M. Tulp, and R. van den Hoven, 1991: Effect of an isoxsuprine-resin preparation on blood flow in the equine thoracic limb. Vet. Rec. 129, 427-429.
15. Elliott, J., 2000: Isoxsuprine: more questions than answers. Equine Vet. J. 32, 90-91.
16. 2-adrenoceptor agonists (romifidine, detomidine and xylazine) in the horse. J. Vet. Pharmacol. Ther. 15, 194-201.
17. Erkert, R. S., and C. G. MacAllister, 2002: Isoxsuprine hydrochloride in the horse: a review. J. Vet. Pharmacol. Ther. 25, 81-87.
18. Fiocre, B., and J. C. Rioux, 1974: Emploi de l'isoxsuprine en obstetrique veterinairé. Bull. Men. Soc. Vét. Prat. Fr. 58, 23-31.
19. Gameiro, G. H., M. T. Arthuri, C. H. Tambeli, and M. C. Ferraz de Arruda Veiga, 2003: Effects of ethanol on deep pain evoked by formalin injected in TMJ of rat. Life Sci. 73, 3351-3361.
20. Harkins, J. D., G. D. Mundy, S. Stanley, W. E. Woods, R. A. Sams, D. R. Richardson, and T. Tobin, 1996: Character and duration of pharmacological effects of intravenous isoxsuprine. Equine Vet. J. 28, 320-326.
21. Harkins, J. D., G. D. Mundy, S. Stanley, W. E. Woods, R. A. Sams, D. R. Richardson, S. C. Grambow, and T. Tobin, 1998: Absence of detectable pharmacological effects after oral administration of intravenous isoxsuprine. Equine Vet. J. 30, 294-299.
22. den Hertog, A., 1976: The effects of isoxsuprine on non-myelinated nerve fibres. Eur. J. Pharmacol. 39, 283-286.
23. Ingle-Fehr, J. E., and G. M. Baxter, 1999: The effect of oral isoxsuprine and pentoxifylline on digital and laminar blood flow in healthy horses. Vet. Surg. 28, 154-160.
24. Joujou-Sisic, K., P. E. Andren, U. Bondesson, E. Fredriksson, C. I. Larson, P. Kallings, and S. G. B. Persson, 1996: A pharmacokinetic study of isoxsuprine in the horse. In: Proceedings of the 11th International Conference of Racing Analyst and Veterinarians Brisbane, Australia. pp. 453-458. R & W Publications, Newmarket, UK.
25. Kamerling, S. G., W. M. Cravens, and C. A. Bagwell, 1988: Objective assessment of detomidine-induced analgesia and sedation in the horse. Eur. J. Pharmacol. 151, 1-8.
26. Kawamata, T., K. Omote, H. Sonoda, M. Kawamata, and A. Namiki, 2000: Analgesic mechanisms of ketamine in the presence and absence of peripheral inflammation. Anesthesiology 93, 520-528.
27. Kirker-Head, C. A., K. A. Stephens, R. L. Toal, and D. O. Goble, 1986: Circulatory and blood gas changes accompanying the development and treatment of induced laminitis. J. Equine Vet. Sci. 6, 293-301.
28. Matthews, N., R. D. Gleed, C. E. Short, and K. Burrows, 1986: Cardiovascular and pharmacokinetic effects of isoxsuprine in the horse. Am. J. Vet. Res. 47, 2130-2133.
29. Nolan, A., A. E. Waterman, and A. Livingston, 1988: The correlation of the thermal and mechanical antinociceptive activity of pethidine hydrochloride with plasma concentrations of the drug in sheep. J. Vet. Pharmacol. Ther. 11, 97-102.
30. Rose, R. J., J. R. Allen, D. R. Hodgson, and J. R. Kohnke, 1983: Studies on isoxsuprine hydrochloride for the treatment of navicular disease. Equine Vet. J. 15, 238-243.
31. Skotnicki, S. H., G. van Gaal, and P. F. Wijn, 1984: The effectiveness of isoxsuprine in patients with intermittent claudication. Angiology 35, 685-693.
32. Suda, T., N. Maeda, D. Shimizu, E. Kamitsubo, and T. Shiga, 1982: Decreased viscosity of human erythrocyte suspension due to drug-induced spherostomatocytosis. Biorheology 19, 555-565.
33. Sumano, H., M. L. Hoyos, and I. Lizarraga, 1997: Tratamiento de la laminitis en el equino. Med. Vet. 14, 595-609.
34. Turner, A. S., and C. M. Tucker, 1989: The evaluation of isoxsuprine hydrochloride for the treatment of navicular disease: a double blind study. Equine Vet. J. 21, 338-341.
35. Waterman, A. E., A. Livingston, and A. Amin, 1991: Further studies on the antinociceptive activity and respiratory effects of buprenorphine in sheep. J. Vet. Pharmacol. Ther. 14, 230-234.
36. Wilson, J. H. G., and L. Bolhuis, 1986: Controlled clinical studies in Europe with isoxsuprine hydrochloride for the treatment of navicular disease and sesamoidosis in horses. Ir. Vet. J. 40, 10-12.
37. Zimmerman, M., 1983: Ethical guidelines for investigation of pain on conscious animals. Pain 16, 109-110.